Sotac Pharmaceuticals Ltd

Sotac Pharmaceuticals Ltd

Sotac Pharmaceuticals Limited was originally formed and registered as a Partnership Firm under the Partnership Act 1932 in the name of M/s Sotac Pharmaceuticals pursuant to a Deed of Partnership dated October 28 2015. Thereafter M/s. Sotac Pharmaceuticals was converted from Partnership Firm to a Private Limited Company in the name of Sotac Pharmaceuticals Private Limited dated December 18 2015 from the Assistant Registrar of Companies Gujarat. Later on Company converted into a Public Limited Company and the name of Company was changed to Sotac Pharmaceuticals Limited' dated November 22 2022 issued by Registrar of Companies Ahmedabad.The Company is a part of SOTAC Group based at Gujarat and is engaged in manufacturing of pharmaceutical products for different marketers on loan license or contract manufacturing basis. The Company is pharma manufacturer specializing in manufacturing of a wide range of pharmaceutical products such as Non Beta-Lactam (general) tablets beta-lactam coated tablets beta-lactam uncoated tablets Non Beta-Lactam (general) capsules beta-lactam capsules oral liquid dry syrup and external preparations such as nasal spray relief spray and cream. The Company's therapeutic portfolio include Anti-Diabetic Anti-Psychotic Vitamins Minerals Iron Anti-Cold AntiAllergic Derma Products Antacid Anti-Ulcerants PPI Anti-Emetics Cardiac Anti-Hypertensives Analgesic AntiPyretic Anti-Inflammatory Anti-Bacterial Anti-Viral General Antibiotics IP-Lactams & Non-IP-Lactams Anti-Fungal Cephalosporin. Consequently as a Group it cater to a wide spectrum of companies for formulation development clinical batch production commercial scale productions.The Company commenced manufacturing facility in year 2017 which had an installed capacity to manufacture 90 Crore tables / year 14 Crore Capsules / year. Later in 2022 the Company acquired 71% holding in SOTAC Healthcare Private Limited and 100% holding in SOTAC Research Private Limited thus making them as wholly owned Subsidiary Companies in April 2022. Thereafter it started a new venture SOTAC Lifescience Private Limited and held 51% of total paid-up capital in it. The Company is planning to come out with a Initial Public offer consisting of upto 3000000 Equity Shares through Fresh issue.